Ann-Sofie M.E. Schauwvlieghe

Comparing the Effectiveness of Bevacizumab to Ranibizumab in Patients with Exudative Age-Related Macular Degeneration. The BRAMD Study

Ann-Sofie M.E. Schauwvlieghe, Greet Dijkman, J. M. M. Hooymans et al. · PLoS ONE · 2016 · 78 citations · Full text

PREDICTIVE VALUE OF OPTICAL COHERENCE TOMOGRAPHIC FEATURES IN THE BEVACIZUMAB AND RANIBIZUMAB IN PATIENTS WITH DIABETIC MACULAR EDEMA (BRDME) STUDY

Ward Fickweiler, Ann-Sofie M.E. Schauwvlieghe, Reinier O. Schlingemann et al. · Retina · 2017 · 43 citations

Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Retinal Vein Occlusion

Maartje J.C. Vader, Ann-Sofie M.E. Schauwvlieghe, Frank D. Verbraak et al. · Ophthalmology Retina · 2020 · 27 citations · Full text

Comparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular Edema: a randomized clinical trial (the BRDME study)

Ann-Sofie M.E. Schauwvlieghe, Greet Dijkman, J. M. M. Hooymans et al. · BMC Ophthalmology · 2015 · 18 citations · Full text

Antiplatelet and Anticoagulant Drugs Do Not Affect Visual Outcome in Neovascular Age-Related Macular Degeneration in the BRAMD Trial

Gabriëlle H.S. Buitendijk, Ann-Sofie M.E. Schauwvlieghe, Johannes R. Vingerling et al. · American Journal of Ophthalmology · 2018 · 16 citations

Thrombosis, Ocular Disease, Anticoagulant Drugs Do +10